GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists (Q27025974)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists |
scientific article |
Statements
GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists (English)
7 references
Joseph R Moskal
Ronald Burch
Jeffrey S Burgdorf
Roger A Kroes
Patric K Stanton
20 November 2013
1 February 2014
2 references
12 August 2020
21 September 2020
9 references
31 July 2019
2 October 2019
20 November 2019
28 November 2019
15 December 2019
12 August 2020
21 September 2020
Identifiers
2 references
2 references
2 references